2 Search strategy and inclusion criteria This mini-review was based on a targeted literature search conducted in PubMed/MEDLINE and Scopus from January 2015 to August 2025, using the keywords GLP-1 receptor agonists, exercise, physical activity, obesity, type 2 diabetes, and weight loss. Additional terms ( lean mass, body composition, insulin sensitivity, cardiometabolic, combined intervention ) were used in secondary searches
He was hospitalized for 13 days, undergoing several procedures to treat his condition
Ozempic has been shown to cause thyroid tumors and thyroid cancer in animals
29 Early studies posited that single-stranded RNA could not form double-stranded structures
"But the problem is compounding: Novo Nordisk CEO Lars Fruergaard Jrgensen said in March that the gap between demand for weight-loss drugs and the supply is significant enough to take years to close." Per CNN, "U.S
Tirzepatide Tirzepatide is currently the only long-acting glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 dual receptor agonist